Sale of Swiss orthopedic company Mathys to Colfax Corporation
Lenz & Staehelin is advising the Mathys family as Sellers in connection with the sale of the Swiss orthopedic company Mathys AG Bettlach to NYSE listed Colfax Corporation. Mathys is an international group headquartered in Switzerland which develops, produces and distributes implants for artificial joint replacements and biomaterials for surgical treatments of bone defects with production sites in Switzerland and Germany. The transaction will result in Mathys joining Colfax' subsidiary DJO, a global provider of medical technologies. It is expected to close in the third quarter of 2021, subject to regulatory approvals and other closing conditions.
The L&S team includes partner Matthias Wolf, senior associates Iliana Djagova and Robin Hauser and associate Sven Infanger (all Corporate/M&A). Senior associate Patrick Schärli advised on capital markets and partner Astrid Waser and associate Sandro Travaglini on antitrust and regulatory aspects.